Nichepharm Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 6.50 Cr
as on 10-12-2024
- Paid Up Capital ₹ 5.97 Cr
as on 10-12-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 560.37%
(FY 2023)
- Profit 405.73%
(FY 2023)
- Ebitda 1112.74%
(FY 2023)
- Net Worth -18.38%
(FY 2023)
- Total Assets -12.96%
(FY 2023)
About Nichepharm Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.50 Cr and a paid-up capital of Rs 5.97 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chetan Sobti and Nitin Sobti serve as directors at the Company.
- CIN/LLPIN
U24230HR2019PTC083085
- Company No.
083085
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Nichepharm Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Sobti  | Director | 16-Oct-2019 | Current |
| Chetan Sobti | Director | 16-Oct-2019 | Current |
Financial Performance and Corporate Structure Insights of Nichepharm Lifesciences.
Nichepharm Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 560.37% increase. The company also saw a substantial improvement in profitability, with a 405.73% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nichepharm Lifesciences?
In 2024, Nichepharm Lifesciences had a promoter holding of 76.20% and a public holding of 23.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Carewell Pharmapack International Private LimitedActive 4 years 10 monthsChetan Sobti is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nichepharm Lifesciences?
Nichepharm Lifesciences has a workforce of 199 employees as of Dec 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nichepharm Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nichepharm Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
